Stoneridge Investment Partners’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
SCM
6CM
WP
CCM
GCGM
DMC
HM
Stoneridge Investment Partners's GUTS Position: Q4 2025 in Review
Stoneridge Investment Partners sold out of Fractyl Health (GUTS) in Q4 2025, closing a stake of 23,721 shares — an estimated $38K sold.
Stoneridge Investment Partners first reported a position in GUTS in Q4 2024 and held it in 4 quarters. The position peaked at $45K in Q4 2024. 97 funds tracked by Wall St. Rank hold GUTS as of Q4 2025.
- Stoneridge Investment Partners reported no remaining Fractyl Health position as of Q4 2025 after selling out during the quarter.
- Stoneridge Investment Partners sold 23,721 Fractyl Health shares in Q4 2025, an estimated $38K.
- Stoneridge Investment Partners first reported a position in Fractyl Health in Q4 2024 and held it in 4 quarters.
- Stoneridge Investment Partners's Fractyl Health position peaked at $45K in Q4 2024.
- 97 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2025.
Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.